PDZRN4 suppresses lung adenocarcinoma progression via inhibiting ubiquitin-mediated HIF-1A degradation
Year: 2025
Type: article
Language: en
Topic: Mechanisms of cancer metastasis
Authors and affiliations:
raw_author_name: Honghao Li
raw_affiliation_strings: Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
The Third Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, China
raw_author_name: Junfeng Wu
raw_affiliation_strings: Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
The Third Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, China
raw_author_name: Hua Dai
raw_affiliation_strings: Department of Pathology, The First Affiliated Hospital of Nanchang University, Nanchang, China
raw_author_name: Jiaming Li
raw_affiliation_strings: Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, 533000, China
raw_author_name: Xiaoyan Bai
raw_affiliation_strings: Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
raw_author_name: Yueli Sun
raw_affiliation_strings: Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
raw_author_name: Jiaxin Lin
raw_affiliation_strings: Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
raw_author_name: Yangsi Li
raw_affiliation_strings: Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
raw_author_name: Peng Li
raw_affiliation_strings: Institute of Drug Discovery, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
raw_author_name: Lingchao Shi
raw_affiliation_strings: Institute of Drug Discovery, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
raw_author_name: Zhen Wang
raw_affiliation_strings: Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
raw_author_name: Haiyan Tu
raw_affiliation_strings: Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
raw_author_name: Ee Ke
raw_affiliation_strings: Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. Elieen_ke@126.com